VALORANT player profile · North America region · Account level 454 · 0 profile views
Current rank: ASCENDANT 2 - 0 RR (as of last recorded competitive match, 2026-06-14).
Peak recorded rank: IMMORTAL 1 - 24 RR (reached 2026-05-27).
Ranks derive from recorded ranked matches; games played while untracked may not be reflected.
| Tracked matches | 275 |
|---|---|
| Win rate | 50.6% (41 W / 40 L over 165 matches with recorded stats) |
| K/D | 1.29 (3657 kills / 2844 deaths / 712 assists) |
| Average combat score | 4670 |
| Headshot rate | 29.0% |
| Date | Mode | Map | Agent | Result | K/D/A | ACS | RR |
|---|---|---|---|---|---|---|---|
| 2026-07-09 | Competitive | Sunset | Sova | W | 15/8/5 | 212 | - |
| 2026-07-07 | Competitive | Breeze | Sova | L | 17/16/3 | 177 | - |
| 2026-07-07 | Deathmatch | Ascent | Skye | - | 40/18/1 | 11310 | - |
| 2026-07-07 | Deathmatch | Sunset | Vyse | - | 7/12/2 | 2306 | - |
| 2026-07-04 | Competitive | Ascent | Sova | L | 14/17/3 | 167 | - |
| 2026-07-04 | Competitive | Split | Raze | W | 12/14/7 | 173 | - |
| 2026-07-04 | Competitive | Haven | Phoenix | W | 8/11/6 | 157 | - |
| 2026-06-24 | Competitive | Ascent | Sova | L | 23/13/7 | 302 | - |
| 2026-06-24 | Competitive | Ascent | Sova | W | 19/8/6 | 260 | - |
| 2026-06-22 | Deathmatch | Lotus | Gekko | - | 22/14/1 | 6616 | - |
| 2026-06-18 | Deathmatch | Split | Iso | - | 34/23/5 | 10729 | - |
| 2026-06-17 | Deathmatch | Fracture | Deadlock | - | 39/21/4 | 11802 | - |
| 2026-06-14 | Competitive | Lotus | - | - | - | - | -19 |
| 2026-06-14 | Competitive | Breeze | - | - | - | - | +0 |
| 2026-06-13 | Competitive | - | - | - | - | - | -6 |
| 2026-06-13 | Competitive | Haven | - | - | - | - | -20 |
| 2026-06-13 | Deathmatch | Lotus | - | - | - | - | +0 |
| 2026-06-13 | Competitive | Ascent | - | - | - | - | +18 |
| 2026-06-13 | Competitive | Split | - | - | - | - | -19 |
| 2026-06-13 | Competitive | Lotus | - | - | - | - | +22 |
Showing 20 of 275 tracked matches. The interactive profile lists all of them.
No penalty records for this player.